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Background: Little is known about immune cell infiltrate type in the kidney allograft of
patients with chronic-active antibody-mediated rejection (c-aABMR).
Methods: In this study, multiplex immunofluorescent staining was performed on 20
cases of biopsy-proven c-aABMR. T-cell subsets (CD3, CD8, Foxp3, and granzyme B),
macrophages (CD68 and CD163), B cells (CD20), and natural killer cells (CD57) were
identified and counted in the glomeruli (cells/glomerulus) and the tubulointerstitial (TI)
compartment [cells/high-power field (HPF)].
Results: In the glomerulus, T cells and macrophages were the dominant cell types
with a mean of 5.5 CD3+ cells/glomerulus and 4 CD68+ cells/glomerulus. The majority
of T cells was CD8+ (62%), and most macrophages were CD68+CD163+ (68%). The
TI compartment showed a mean of 116 CD3+ cells/HPF, of which 54% were CD8+.
Macrophage count was 21.5 cells/HPF with 39% CD68+CD163+. CD20+ cells were
sporadically present in glomeruli, whereas B-cell aggregates in the TI compartment were
frequently observed. Natural killer cells were rarely identified. Remarkably, increased
numbers of CD3+FoxP3+ cells in the TI compartment were associated with decreased
graft survival (p = 0.004).
Conclusions: Renal allograft biopsies showing c-aABMR show a predominance of
infiltrating CD8+ T cells, and increased numbers of interstitial FoxP3+ T cells are
associated with inferior allograft survival.
Keywords: kidney transplantation, pathology, chronic rejection in renal transplant, antibody-mediated allograft
rejection, immune cell
INTRODUCTION
The renal biopsies of patients with chronic-active antibody-mediated rejection (c-aABMR) have
defining histomorphological lesions (1). These characteristic lesions include double contours of
the glomerular basement membrane (transplant glomeropathy) and/or severe peritubular capillary
basement membrane multilayering. In addition, evidence of current or recent antibody interaction
with the vascular endothelium is provided by either linear C4d staining in peritubular capillaries
or moderate microvascular inflammation [(g + ptc) ≥ 2] (2). The presence of donor-specific
antibodies underlies c-aABMR, but the influx of inflammatory cells and rate of loss of renal function
may vary substantially.
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Previously, different studies have reported on the
inflammatory cell types involved in renal allograft rejection.
Hidalgo et al. provided evidence for a possible effector role for
natural killer (NK) cells in endothelial injury during ABMR
(3). In addition, ABMR is associated with both glomerular and
interstitial monocyte infiltration (4–7). Mengel et al. showed
the importance of inflammatory infiltrates in protocol biopsies,
as they were independently associated with allograft survival,
regardless of their location (8). Furthermore, activated cytotoxic
T cells are known to play an important role in the inflammatory
activity and destruction of allograft tissue (9). The increased
presence of cytotoxic granules such as granzyme B have been
associated with acute rejection (10–12). Similarly, FoxP3+
T cells [T regulatory cells (Tregs)] have been identified as
potential crucial players in inflammatory disease and allograft
rejection (13–15).
However, the majority of studies has focused on acute
rejection (both TCMR and ABMR), and there is currently a lack
of data on the presence and clinical relevance of inflammatory
cells in renal allografts of patients with c-aABMR.
In the current study, we used multiplex immunofluorescent
(IF) staining to assess the inflammatory cell composition in the
renal allograft biopsy of patients with c-aABMR. We report on
the presence of various T-cell subtypes, B cells, NK cells, and
myeloid cells in both glomeruli and the tubulointerstitial (TI)
compartment. In addition, the association between location and
quantity of the different inflammatory cells with allograft survival
was analyzed.
MATERIALS AND METHODS
Study Population and Material
Twenty patients with biopsy-proven c-aABMR between 2010
and 2014 were included in this retrospective study. Sufficient
formalin-fixed paraffin-embedded (FFPE) material after
diagnostic process was needed to be included for further
FIGURE 1 | Multiplex immunofluorescent (IF) staining image of the antibody combination CD3, CD8, and granzyme B. (a) Red, CD3; (b) white, DAPI; (c) blue, CD8;
(d) green, granzyme B; (e) combination of CD3, CD8, granzyme B, and DAPI. The arrow marks a CD3+CD8+granzyme B+ cell representing a CD8+ cytotoxic T cell.
The circle encloses a CD3+granzyme B+ cell representing a CD4+ cytotoxic T cell. The square encloses a CD3+CD8+ cell representing a CD8+ T cell.
analysis. Renal transplant biopsies were all for cause and deemed
necessary by the treating nephrologist due to a unexplained
decline in renal allograft function with or without new onset
proteinuria. All stained slides were re-evaluated and scored by
two blinded pathologists according to the Banff 15 criteria (16).
Donor-specific antibodies (DSA) were retrospectively assessed
for all patients. The study was approved by the Medical Ethical
Committee of the Erasmus MC (MEC-2019-0308).
Staining
For routine diagnostic analysis, 3µm sections were cut from
the FFPE tissue and stained by H&E, periodic acid–Schiff–
diastase, and Jones according to standardized diagnostic protocol
at the Department of Pathology at the Erasmus Medical
Center. Immunofluorescence staining was performed on snap-
frozen tissue sections [immunoglobulin G (IgG), IgA, IgM,
C3, C1q, kappa, and lambda] to exclude immune-complex-
mediated disease.
Additional quadruple multiplex IF staining was performed
on 4µm FFPE sections. Multiplex IF staining was performed
using the antibody combination of CD3, CD8, and granzyme B
for CD4+ T cells, CD8+ cytotoxic T cells both with or without
granzyme B presence (Figure 1). Second, CD20 was used as a
B-cell marker, and for the identification of macrophages, the
pan macrophage marker CD68 was used in combination with
CD163 to distinguish the M2 macrophage subtype (profibrotic)
(Figure 2). Lastly, a combination of CD3, FoxP3, and CD57 was
used to identify CD3+FoxP3+ regulatory T cells and NK cells
(Figure 3). 4
′
,6-Diamidino-2-phenylindole (DAPI) was used in
all stainings to visualize the nuclei. Multiplex IF was performed
as previously described by Punt et al. (17). In brief, after
deparaffinization, ethylenediaminetetraacetic acid (pH 9) antigen
retrieval was performed in a microwave. Next, three different
combinations of primary antibodies were applied to the slides.
The first mixture consisted of the antibodies anti-CD3 (rabbit
polyclonal, ab828; Abcam), anti-CD8 (mouse monoclonal IgG2b,
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FIGURE 2 | Multiplex immunofluorescent (IF) staining image of the antibody combination CD20, CD68, and CD163. (a) Red, CD20; (b) white, DAPI; (c) blue, CD163;
(d) green, CD68; (e) combination of CD20, CD68, CD163, and 4
′
,6-diamidino-2-phenylindole (DAPI). The arrow marks a CD68+ cell representing a single positive
CD68 macrophage. The circle encloses a CD20+ cell representing a B cell. The square encloses a CD68+CD163+ cell representing a double positive M2
macrophage subtype.
FIGURE 3 | Multiplex immunofluorescent (IF) staining image of the antibody combination CD3, CD57, and FoxP3. (a) Red, CD3; (b) white, DAPI; (c) blue, FoxP3; (d)
green, CD57; (e) combination of CD3, CD57, FoxP3, and 4
′
,6-diamidino-2-phenylindole (DAPI). The circle encloses a CD3+CD57+ cell representing a CD3+CD57+
cytotoxic T cells. The square encloses a CD3+FoxP3+ cell representing a FoxP3+ T regulatory cell.
4B11; Novocastra), and anti-Granzyme B (mouse monoclonal
IgG2a, GRB-7, DAKO). The second mixture consisted of the
antibodies anti-CD3 (rabbit polyclonal, ab828; Abcam), anti-
FoxP3 (mouse monoclonal IgG1, 236A/E7, Abcam), and anti-
CD57 (mouse monoclonal IgM, HNK-1; developed in Leiden
University Medical Center). The third mixture comprised
the antibodies anti-CD20 (mouse-IgG2a, L2G, Ventana), anti-
CD163 (rabbit, ab100909, Abcam), and anti-CD68 (mouse-IgG1,
123C3, Ventana). The first combination was visualized using
a combination of fluorescent antibody conjugates (Molecular
Probes, ThermoFisher): goat antirabbit IgG–Alexa Fluor 546,
goat antimouse IgG2b–Alexa Fluor 647, and goat antimouse
IgG2a–Alexa Fluor 488. The second combination was visualized
using goat antirabbit IgG–Alexa Fluor 546, goat antimouse
IgG1–Alexa Fluor 647, and goat antimouse IgM–Alexa Fluor
488. The third combination was visualized using goat antimouse
IgG2a–Alexa Fluor 546, antirabbit IgG–Alexa Fluor 647, and goat
antimouse IgG1–Alexa Fluor 488. The panels were optimized
using normal human tonsil and normal renal cortical tissue.
Detection and Analysis
Images of the slides were taken for further analysis on a confocal
laser scanning microscope in multitrack setting (Zeiss LSM700,
Zeiss, Jena, Germany). An LCI Plan-Neofluar 25×/0.8 Imm Korr
DIC objective (Zeiss) was used.
If possible, tissue sections were scanned in their entirety. For
the glomerular cell counts, all available glomeruli per silver-
stained tissue were included. The glomerular compartment cell
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counts were represented as the average number of whole cells
per glomeruli. Tubulo-interstitial compartment cell counts were
represented as the average number of whole cells per high-power
field (HPF, 40×). A blinded and random selection of 3 HPF
was analyzed for the TI compartment cell counts. All cells were
counted using the Zen 2.3 SP1 software.
Statistical Analysis
Normally distributed data are expressed as mean ± SD, non-
normally distributed data as median (interquartile range). All
statistical analysis were performed using Graphpad Prism 6 and
SPSS software version 24. Statistical significance was calculated
using unpaired t-test for continuous variables, Mann–Whitney
U-test for ordinal variables, and chi-squared or Fisher exact
test for categorical variables. A P < 0.05 was considered
statistically significant.
Graft survival curves, starting at time of c-aABMR diagnosis,
were censored for death with functioning graft and analyzed by
Kaplan–Meier with log-rank test. For the analysis of association
of inflammatory cells with allograft survival, both the glomerular
and TI compartment cell count were divided dichotomously
based on the mean cell count.
TABLE 1 | Main clinical features at time of chronic-active antibody-mediated
rejection (c-aABMR) diagnosis.
N = 20
Recipients age, years
(IQR)
54 (44–63)
Male, n (%) 14 (70)
Donor age, years (IQR) 52 (40–59)
Prior transplantation, n (%) 7 (35)
Living donation, n (%) 13 (65)
HLA mismatch, median
(IQR)
3 (2–4)
Time post-transplantation,
years (IQR)
3.6 (1.8–7.5)
eGFR, ml/min/1.73 m2
(IQR)
29 (24–38)
Proteinuria, g/L (IQR) 0.75
DSA positive, n (%) 9 (45)*
HLA class I 2
HLA class II 8
C4d positive, n (%) 10 (50)
Renal disease, n (%) Diabetic nephropathy 5 (25)
Hypertensive nephropathy 2 (10)
Reflux nephropathy 2 (10)
Chronic pyelonephritis 2 (10)
Cystic kidney disease 2 (10)
Other 7 (35)
Immunosuppressive
therapy, n (%)
Tacrolimus 16 (80)
MMF 18 (90)
Corticosteroids 9 (45)
Other 1 (5)
*One patient had both HLA class I and HLA class II DSA present.
RESULTS
Baseline Characteristics
Clinical and histological characteristics of the included patients
are shown in Table 1 and Figure 4. The mean age of the patients
was 54 years at the time of transplant biopsy. Mean time
point of biopsy post-transplantation was 3.6 years. Patients were
predominantly treated with an immunosuppressive regimen
using a combination of calcineurin inhibitors (mainly tacrolimus,
80%) and mycophenolate mofetil (90%). Mean follow-up was
3.4 years (range, 0.7–8.3 years) or until graft failure (either
retransplantation or return to dialysis). Two patients died with
a functioning graft during follow-up.
Forty-five percent of patients were DSA positive at the time
of biopsy, 50% showed linear positive C4d staining of the
peritubular capillaries, and all biopsies showed microvascular
inflammation. Furthermore, all patients had severe double
contours of the glomerular basement membrane (cg) present in
their biopsy with moderate to severe chronic damage [interstitial
fibrosis and tubular atrophy (IFTA)].
CD3+, CD8+, Granzyme B+ T Cells
First, we analyzed the number of glomerular T cell (CD3+
T cells), CD8+ T cells (CD3+CD8+ T cells), CD4+ T
cells (CD3+CD8− T cells), CD8+granzyme B+ T cells, and
CD4+granzyme B+ T cells by quadruple immunostaining.
Figure 5 shows the distribution as well as the mean number of
inflammatory cells per glomerulus per biopsy. A mean total of
5.5 CD3+ cells were present per glomerulus with a range of 0.8–
9.6 CD3+ cells. CD8+ T cells were predominant, making up
61.7% of CD3+ T cells with a mean of 3.4 cells per glomerulus. A
minority of CD8+ T cells (46%) and CD4+ T cell (23%) showed
cytotoxic potential as measured by coexpression of granzyme
B. Inflammatory cell counts were then performed for the TI
compartment (Figure 6). Although substantial variations were
observed in the number of infiltrating cells among the biopsies,
large areas of CD3+ T cells were abundantly present within the
TI compartment. The TI showed a mean CD3+ cell count of
116.2 per HPF. The majority of CD3+ T cells present in the TI
FIGURE 4 | Distribution of Banff lesions at time of chronic-active
antibody-mediated rejection (c-aABMR) diagnosis.
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FIGURE 5 | Distribution of mean number of inflammatory immune cells per
glomerulus per biopsy.
FIGURE 6 | Distribution of mean number of inflammatory immune cells per
high-power field (HPF) per biopsy.
represented CD8+ T cells (53.9%) with an average cell count of
62.6 per HPF followed by CD4+ T cells (46.2%) with 53.6 positive
cells per HPF. In contrast to the glomeruli, there were hardly any
CD8+ granzyme B+ T cells (7% of total CD3+ T cells, 8.2 cells
per HPF) and CD4+ granzyme B+ T cells (1.5% of total CD3+ T
cells, 1.7 cells per HPF) present.
No significant association was found for the presence of
CD3+ T cells and the T-cell subsets in the glomeruli and TI
compartment with regard to allograft survival or DSA presence.
CD3+, FoxP3+ T Cells, and CD57+ NK Cells
The second quadruple multiplex IF staining identified CD57+
NK cells (CD3−), CD3+FoxP3+ regulatory T cells, and
CD3+CD57+ T cells.
The glomeruli showed low counts of CD57+ and
CD3+CD57+ cells in this multiplex IF staining (Figure 5).
Almost 40% of biopsies showed no presence of CD57+ or
CD3+FoxP3+ cells in the glomeruli. The remaining biopsies
showed a mean of 0.67 CD57+, 0.56 CD3+CD57+, and 0.32
FoxP3+ cells per glomerulus. CD3+CD57+ cytotoxic T cells
accounted for 6.7% of CD3+ cells in the glomerulus.
The TI compartment, however, showed a much higher
presence of CD3+FoxP3+ T cells with an average of 11.5
cells per HPF. These cells accounted for 8.5% of the CD3+
cells. A clear distinction into two groups was noticeable
within the biopsies for CD3+FoxP3+ T cells (high vs. low
mean cell count). Fifty percent of biopsies had a high
mean cell count of 19.6 positive cells per HPF vs. a
low mean cell count of 3.4 positive cells per HPF. The
increased presence of CD3+FoxP3+ T cells was significantly
associated with a decreased allograft survival (Figure 7A).
Patients with high CD3+FoxP3+ T cell rates had a graft
survival of 2.1 vs. 5.3 years in the patients with low FoxP3
presence (p= 0.004).
Similar to what was observed for the glomeruli, the CD57+
cell count in the TI was low with a mean of 1.7 cells per HPF and
CD3+CD57+ T cells accounted for only 0.8% of CD3+ cells in
this compartment.
CD68+, CD163+ Macrophages, and CD20+
B Cells
The third multiplex IF staining panel included markers for
macrophages (CD68+), M2 macrophages (CD68+CD163+), and
B cells (CD20+).
CD20+ cells were sporadically present in glomeruli with a
mean number of 0.16 positive cells per glomerulus. Interestingly,
45% of biopsies hardly contained any B cells in the glomeruli.
The macrophages (CD68+ cells) represented mean number
of almost four cells per glomerulus. The majority (68%) was
CD68+CD163+ with a mean positive cell count of 2.3 per
glomerulus. A scattered distribution of macrophages was visible
with ranges of 0–6 positive cells per glomerulus. No significant
association with graft function or DSA presence was found for
macrophage or B cell presence in the glomeruli (data not shown).
In contrast to the glomeruli, the TI compartment showed a
higher percentage of CD68+ cells (61%) with a mean positive cell
count of 13.2 per HPF. CD68+CD163+ macrophages accounted
for 39% of macrophages with a mean of 8.4 positive cells
per HPF. The presence of total CD68+ and CD68+CD163+
macrophages in the TI compartment showed a near significant
inverse association with graft survival (p= 0.08) (Figure 7B).
Furthermore, a mean number of 36.8 positive CD20 cells
was counted in the tubulointerstitium. However, as with the
CD3+FoxP3+ T cells, a clear distribution into two groups was
visible. Forty-five percent of the biopsies were found to present
CD20+ cells in nodular formation with a mean of 74.5 CD20-
positive cells per HPF. The remaining biopsies reached a mean
of 3.4 CD20+ cells per HPF. The distribution in B cell was not
significantly associated with graft survival (p = 0.13). However,
patients with increased numbers of B cells in the TI compartment
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FIGURE 7 | (A) Renal allograft survival after chronic-active antibody-mediated rejection (c-aABMR) diagnosis in relation to CD3+ FoxP3+ cell presence in the
tubulointerstitial compartment; (B) renal allograft survival after c-aABMR diagnosis in relation to overall macrophage (CD68+ and CD163+) presence in the
tubulointerstitial compartment.
had the tendency to have DSA present in the serum at time of
biopsy. However, this was not statistically significant (p= 0.078).
DISCUSSION
No detailed description on inflammatory cells in renal allograft
biopsies showing c-aABMR is currently available. Through
multiplex IF staining, we evaluated inflammatory cell presence
in glomeruli and TI compartment and related their presence
to renal allograft survival. Our study is the first detailed report
on the localization and immunophenotypic composition of
inflammatory cells in c-aABMR of the renal allograft. Most
notably T cells and macrophages were observed within the
glomeruli and/or in the TI compartment. Of interest is the
increased presence of FoxP3+ T cells in the TI compartment,
which is significantly associated with inferior allograft survival.
Renal biopsies showing c-aABMR demonstrated vast areas
of inflammatory cells denoting the presence of an ongoing
immune-mediated process. Substantial numbers of T cells and
macrophages were present in the glomeruli and TI compartment.
The glomerular compartment predominantly comprised of
CD8+ cytotoxic T cells (granzyme B+ and CD57+) and
M2 macrophages (CD68+ and CD163+), but there was a
relatively low amount of single positive CD57+ NK cells in
the glomeruli. Previous reports have provided evidence for
the presence of NK cell transcriptomes marking NK cells
as an important player in the pathogenesis of c-aABMR (3,
18, 19). Our study using multiplex IF staining could not
confirm the presence of these cells as only a small number
of NK cells were present in allografts within the setting of c-
aABMR. However, Parkes et al. previously demonstrated that
over 50% of increased transcripts in CD16a-activated NK cells
are also increased in activated CD8+ T cells. The NK and
T cells shared transcripts for effector cytokines, chemokines,
and other molecules related to effector cell function (18).
Of interest was the presence of CD3+CD57+ T cells in the
glomeruli. Several biopsies showed infiltrates of CD3+CD57+
T cells, and their presence accounted for 6.7% of CD3+ cells
in the glomerulus. Although these cells have not been further
phenotyped, they might indicate the presence of terminally
differentiated effector CD8+CD57+ cytotoxic T cell, possessing
NK cell-like properties. These cells are known to have strong
cytotoxic potential with high expression of both granzyme B
and perforin. The expression of these cytolytic molecules is
considerably higher in CD8+CD57+ T cells than in their CD57−
counterpart (20). This type of T cell is presumed to increase
in frequency with chronic immune activation as well as during
normal aging (21–23). In addition, Björkström et al. proposed
that in the setting of chronic immune activation terminal, CD8+
T cells can acquire the ability to express FcγRIIIA (CD16) (24).
CD16 expressed on CD8+ T cells functioned independently
from the T-cell receptor and was able to generate effector
cytokine production as well as degranulation. CD16 function
has been well-studied on NK cells and is best characterized
for its role in antibody-dependent cellular cytotoxicity (25).
The presence of these cells in combination with the high
percentage of granzyme B+ T cells found in the glomeruli suggest
possible severe cytotoxic damaging effects in the glomerular
compartment (26, 27).
The glomerular compartment also contained high numbers
of macrophages with widespread distribution in number of
CD68+ cells per glomerulus. This finding is in accordance
with previous literature in which macrophages were significantly
associated with clinical rejection and severity, regardless of
type of rejection (5–7). Although not statistically significant,
the increased presence of macrophages in the TI compartment
showed a possible association with graft survival. In addition, it
was van den Bosch et al. who provided evidence for increased
glomerular infiltration with CD68+CD163+ macrophages in c-
aABMR compared to ABMR and TCMR (7). In accordance
with this finding, CD68+CD163+ macrophages were the
predominant subset in the glomeruli (68%), contrary to the TI
compartment (39%).
T cells and macrophages were also the main inflammatory
cells in the TI compartment but with a different
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immunophenotypic distribution. The predominant T cells
were either CD4+ or CD8+ T cells and of interest was the
observation that, in contrast to the glomeruli, relatively
few CD8+ T cells expressed granzyme and/or CD57. The
areas of the TI compartment with diffuse cellular infiltrates
could suggest a possible contributing role for T cells in c-
aABMR. Previously, Mengel et al. identified the importance of
inflammatory cell infiltrates in protocol biopsies, specifically
in areas of IFTA (8). These areas are now classified as i-
IFTA/t-IFTA and have also been incorporated into the
latest Banff meeting report (2). Although we did not find
an association for T-cell infiltrates with (inferior) graft
survival, further study is needed to assess if i-IFTA and
t-IFTA play an important role in the outcome of graft
with c-aABMR.
Of interest in the TI compartment are the CD3+FoxP3+
cells. We demonstrated that patients with increased FoxP3+
Tregs in the TI compartment had inferior renal allograft
survival compared to those with few Tregs in the TI
compartment. Initially, FoxP3 was identified as the transcription
molecule required for Treg development (28). Its presence in
certain autoimmune diseases suggests an important role in
immune tolerance (29, 30). Similarly, several studies regarding
transplantation have shown upregulation of FoxP3 during
episodes of acute rejection (15, 31, 32). However, the significance
of FoxP3+ T cell presence remains uncertain as these studies
have shown conflicting data on the relation with graft survival
(15, 33–35). For instance, Yapici et al. and Veronese et al. found
a correlation between decreased graft survival and an increased
density of Foxp3-expressing cells in acute rejection (35, 36).
Our data showing increased presence of FoxP3+ Tregs in c-
aABMR might be interpreted as an end result of widespread T-
cell activation, rather than the cause of poor allograft survival
(34). This is in accordance with Bunnag et al., who presented
FoxP3 presence as a time-dependent feature reflecting chronic
inflammation and showed association with IFTA, rather than
FoxP3 as an independent predictor of outcome (34).
In addition, the association with inferior graft survival
might be related to the potential of these FoxP3+ T cell
to easily differentiate into interleukin (IL)-17 producing
T helper 17 (Th17) cells, as previously demonstrated in
other autoimmune-mediated inflammatory diseases (37). Under
normal circumstances, the transcription of FoxP3 in T cells is
mainly induced by transformation growth factor-β. However,
under proinflammatory conditions involving IL-6, believed to
be present in renal allografts during rejection, T cells from a
regulatory pathway can be adapted to an inflammatory pathway
resulting in Th17 (38, 39). Th17 possess highly proinflammatory
capacities rather than immune-regulatory functions.
This is the first study of this nature, describing inflammatory
cell presence in glomeruli and the TI compartment of patients
with c-aABMR. However, it does have a small number of samples.
The presented data are of great interest and provide further
insight into the possible pathogenesis of c-aABMR.
In conclusion, the predominant renal-infiltrating immune
cells in renal biopsies of c-aABMR are CD8+ T cells and
M2 type macrophages in both the glomeruli and the TI
compartment. Interestingly, in c-aABMR, increased numbers of
FoxP3-expressing T cells are significantly associated with poor
renal allograft survival.
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